Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Deal lets Volcano add PAD device to its portfolio

Volcano will pay up to $130 million to acquire AtheroMed, giving Volcano access to a recently FDA-approved treatment for peripheral artery disease (PAD).

Thumbnail

FDA gives PE ultrasound device a green light

The FDA cleared an ultrasound-based infusion technology as a treatment for pulmonary embolism (PE). According to EKOS Corp., its EcoSonic system is the sole minimally invasive endovascular therapy on the market.

MRI algorithm may ID stroke patients at risk of major bleeding

Physicians treating ischemic stroke one day may be able to determine patients’ risk for developing severe intracranial bleeding using an algorithm applied to standard MRI scans.

Tufts University names Dariush Mozaffarian as dean of Friedman School of Nutrition Science and Policy

Tufts University announced today that Dariush Mozaffarian, M.D., Dr.P.H., has been named dean of the Gerald J. and Dorothy R.  Friedman School of Nutrition Science and Policy effective July 1. Mozaffarian joins the Friedman School from Harvard University, where he currently serves as associate professor and co-director of the Program in Cardiovascular Epidemiology at the Harvard School of Public Health (HSPH) and an associate professor in the Division of Cardiovascular Medicine at Harvard Medical School and Brigham and Women’s Hospital.

Thumbnail

DIY PAD therapy: Home-based exercise program improves mobility

Peripheral artery disease (PAD) patients may see long-term, improved mobility and endurance with an exercise program that they can do at home. Participants saw a sustained improvement over baseline at 12 months, increasing their six-minute walk distance by about a third of a football playing field.

Boston Scientific snags Bayer’s peripheral unit for $415M

Boston Scientific will buy the interventional device division at Bayer AG for $415 million. The acquisition will let Boston Scientific widen its portfolio of technologies used to treat coronary and peripheral vascular disease.

Therapy sought to reduce major risk from minor bleeding that can follow stroke

Bleeding into the brain following a stroke doesn't have to be big to be bad, says a researcher exploring a therapy to eliminate the major risk of minor bleeding.

Biotronik portfolio expanded with Fortress Introducer Sheath for peripheral interventions

BIOTRONIK, a leading manufacturer of vascular intervention devices, has expanded its line of reinforced introducer sheaths. Following up on the success of the 4F compatible Fortress Introducer Sheath, the expansion maintains the flexibility and stability of the 4F model, and is now available in 5F and 6F. 

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.